Eclipse
Eclipse was founded with a mission to power the Industrial Evolution. Since 2015, we’ve helped entrepreneurs build exceptional companies that make physical industries more efficient, resilient, and profitable.
Investment focus
Eclipse's portfolio on More Capital spans healthcare & biotech, clean energy & climate, semiconductors & hardware, transportation & logistics. The firm is based in Palo Alto, California, United States. Of the 6 portfolio companies tracked here, 3 have publicly reported valuations totaling approximately $18B.
If your company is backed by Eclipse
Employees at companies backed by Eclipse may encounter this fund's name on their cap table, in board communications, or in funding announcements. Understanding who invests in your employer can provide useful context when evaluating your equity.
What this means for your stock
Institutional investors like Eclipse typically hold preferred shares with rights that differ from the common stock or options held by employees. In a liquidity event, preferred shareholders may have liquidation preferences, anti-dilution protections, or board-level governance rights that affect the value of common equity. The specific terms depend on each company's funding agreements.
Secondary market considerations
Some venture-backed companies allow employees to sell shares on secondary markets, while others restrict transfers. Whether your company permits secondary sales, and under what conditions, is typically governed by the company's equity plan and any applicable right-of-first-refusal provisions — not by the fund itself. However, the presence of institutional investors can sometimes signal the maturity and governance structure of the company.
Eclipse portfolio companies
6 companies tracked on More Capital, sorted by reported valuation. 3 companies do not have a publicly reported valuation.
Top holdings by valuation
By sector
Latest Eclipse news
Industries invested in
Frequent co-investors
Funds that most frequently co-invest alongside Eclipse in the same companies.
Last verified: 2026-05-28
Portfolio data compiled from public filings, press releases, and industry databases. Valuations are reported figures and may not reflect current market conditions. Not investment advice. Consult a qualified advisor before making financial decisions.